VJOncology is committed to improving our service to you

ASCO 2019 | Melanoma retreatment with anti-PD1 therapy

VJOncology is committed to improving our service to you

Allison Betof Warner

Allison Betof Warner, MD, PhD, of the Memorial Sloan Kettering Cancer Center, New York, NY, discusses the long-term outcomes and responses to retreatment in melanoma patients who responded to PD-1 inhibitors. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter